Zusammenfassung
Im Diagnostik-Algorithmus einer nichtalkoholischen Fettlebererkrankung (NAFLD) spielt die histomorphologische Gewebeuntersuchung eine wichtige Rolle und ist zurzeit noch der Goldstandard. In diesem Buchkapitel werden die histomorphologischen Kennzeichen einer NAFLD bzw. die einer nichtalkoholischen Steatohepatitis (NASH) beschrieben und mit histologischen Bildern erläutert. Die gängigsten Scoring-Systeme zur Quantifizierung der nekro-inflammatorischen Aktivität werden beschrieben und deren Unterschiede aufgezeigt. Morphologische Unterschiede zur NAFLD bei Kindern und Besonderheiten in der Zellkernmorphologie werden dargestellt.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Bedossa P, Flip Pathology Consortium (2014) Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. Hepatology 60:565–575
Bedossa P, Poitou C, Veyrie N, Bouillot JL, Basdevant A, Paradis V, Tordjman J, Clement K (2012) Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 56:1751–1759
Brunt EM (2001) Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21:3–16
Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467–2474
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67:328–357
de Alwis NM, Day CP (2008) Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 48(Suppl 1):S104–S112
European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO) (2016) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 64:1388–1402
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Network Nonalcoholic Steatohepatitis Clinical Research (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321
Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434–438
Nobili V, Alisi A, Newton KP, Schwimmer JB (2016) Comparison of the phenotype and approach to pediatric vs adult patients with nonalcoholic fatty liver disease. Gastroenterology 150:1798–1810
Paradis V, Bedossa P (2008) Definition and natural history of metabolic steatosis: histology and cellular aspects. Diabetes Metab 34:638–642
Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T, Lido Study Group (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128:1898–1906
Reis H, Peterek PT, Wohlschlaeger J, Kaiser GM, Mathe Z, Juntermanns B, Sotiropoulos GC, Beckhove U, Canbay A, Wirges U, Scherag A, Treckmann JW, Paul A, Baba HA (2014) Oil Red O-assessed macrosteatosis in liver transplant donor biopsies predicts ischemia-reperfusion injury and clinical outcome. Virchows Arch 464:165–174
Roeb E, Steffen HM, Bantel H, Baumann U, Canbay A, Demir M, Drebber U, Geier A, Hampe J, Hellerbrand C, Pathil-Warth A, Schattenberg JM, Schramm C, Seitz HK, Stefan N, Tacke F, Tannapfel A, Lynen Jansen P, Bojunga J (2015) S2k Guideline non-alcoholic fatty liver disease. Z Gastroenterol 53:668–723
Sanyal AJ, Gastroenterological Association American (2002) AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123:1705–1725
Schwertheim S, Kalsch J, Jastrow H, Schaefer CM, Theurer S, Ting S, Canbay A, Wedemeyer H, Schmid KW, Baba HA (2020) Characterization of two types of intranuclear hepatocellular inclusions in NAFLD. Sci Rep 10:16533
Theurer S, Kalsch J, Schwertheim S, Kathemann S, Baba HA (2020) Histopathological diagnosis and differential diagnosis of nonalcoholic fatty liver disease. Pathologe 41:434–443
Yeh MM, Brunt EM (2014) Pathological features of fatty liver disease. Gastroenterology 147:754–764
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Baba, H.A. (2022). Pathologie. In: Geier, A., Canbay, A., Lammert, F. (eds) Nicht-alkoholische Fettlebererkrankung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-62484-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-662-62484-5_3
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-62483-8
Online ISBN: 978-3-662-62484-5
eBook Packages: Medicine (German Language)